MARKETS
Markets

Roche Secures CE Mark For Cobas Smart E Immunoanalyser Using Same Reagents As High-Throughput Platforms, Enabling Smaller Labs To Bring Testing In-House

Oct 27, 2026 · 02:36 AM ET· updated 39m ago

The cobas smart e immunoanalyser – the newest addition to Roche’s industry-leading cobas immunoassay systems portfolio – is engineered to deliver central-lab performance in a footprint under one square metre. With a

Share
Why It Matters

Roche made a smaller lab machine that works like big ones. Smaller doctors' offices can now run their own tests faster.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.